Islet encapsulation by biomaterials that allow diffusion of nutrients/waste, oxygen, and insulin but prevent infiltration by immune cells and antibodies has been explored as a candidate permanent treatment of T1DM for over 40 years (133–136). This evidence concerns the gene INS and type 1 diabetes mellitus.